The coalition created a readmission-reducing intervention that included personalized transitional care, education, medication reconciliation, follow-up telephone calls and linking patients to community resources.
The authors of the study measured the 30-day unplanned same-hospital readmission rates at an urban academic medical center for a baseline period — spanning from May 1, 2011, to April 30, 2012 — and the intervention period — from Oct. 1, 2012, to May 31, 2014.
Based on data collected from more than 10,600 discharged Medicare fee-for-service patients, the odds of readmission decreased significantly more among the intervention group than among the control population.
“This large-scale readmission reduction program reduced readmissions by 9.3 percent among the full population targeted by the CMS despite being delivered only to high-risk patients. However, it did not achieve the goal reduction set by the CMS,” concluded the study. The CMS goal was 20 percent.
More articles on readmissions:
Untimely nursing care linked to racial disparities in hospital readmission among AMI patients
Testosterone therapy for older men may curb readmissions, help avoid ‘post-hospital syndrome’
CMS 5-star hospitals have lower mortality and readmission rates, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
